Voyager Therapeutics, Inc. (VYGR) News
Track canonical SquawkNews coverage tagged to VYGR, Voyager Therapeutics, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 2 indexed stories across 2 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
VYGR Additional VY1706 (Alzheimer's anti-tau Gene therapy) preclinical data bode well for program/company; reiterate BUY, $12PT @ Canaccord
VYGR Additional VY1706 (Alzheimer's anti-tau Gene therapy) preclinical data bode well for program/company; reiterate BUY, $12PT @ Canaccord
EQUITY | Jul 14, 2026, 12:18 PM UTC
H
Jim Cramer: TE Connectivity Is ‘Terrific,’ Buy This Industrial Stock
On CNBC’s “ Mad Money Lightning Round,” Jim Cramer recommended buying GE Vernova Inc. (NYSE: GEV ), adding that the Charitable Trust has a very big position in the stock. Lending support to his choice, Bernstein analyst
RATES | Jul 01, 2026, 11:49 AM UTC